APO RESEARCH · REPORT
Ursodeoxycholic Acid API
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Product & engineering
Understand the product.
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Selected research
Industry Growth & Trends
Global Ursodeoxycholic Acid API Industry Growth and Trends Forecast to 2032
Market perspective
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
For the application, Ursodeoxycholic Acid API is widely used for Pharmacy and Health Products. The most proportion of Ursodeoxycholic Acid API is used for Pharmacy, and the proportion in 2019 is about 78%.
Read the full market overview
For the regions, Asia-Pacific is the largest consumption place, with a consumption market share nearly 51% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 26%.
For the players, ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhongshan belling, Dipharma Francis, etc. are the leaders of the industry.
Report Scope
This report provides a structured, data-driven view of the global Ursodeoxycholic Acid API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Ursodeoxycholic Acid API market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ursodeoxycholic Acid API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ursodeoxycholic Acid API.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Ursodeoxycholic Acid API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Ursodeoxycholic Acid API Market by Company
ICE
Grindeks
Mitsubishi
Daewoong chemical
PharmaZell GmbH
Dipharma Francis
Zhangshanbelling
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Ursodeoxycholic Acid API Segment by Type
Synthetic UDCA
Extraction UDCA
Ursodeoxycholic Acid API Segment by Application
Pharmacy
Health Products
Ursodeoxycholic Acid API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ursodeoxycholic Acid API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ursodeoxycholic Acid API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ursodeoxycholic Acid API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ursodeoxycholic Acid API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Ursodeoxycholic Acid API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Synthetic UDCA
- Extraction UDCA
Applications
- Pharmacy
- Health Products
Companies covered
- ICE
- Grindeks
- Mitsubishi
- Daewoong chemical
- PharmaZell GmbH
- Dipharma Francis
- Zhangshanbelling
- Erregierre
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ursodeoxycholic Acid API Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Ursodeoxycholic Acid API Sales Estimates and Forecasts (2021-2032)
- 1.3 Ursodeoxycholic Acid API Market by Type
- 1.3.1 Synthetic UDCA
- 1.3.2 Extraction UDCA
- 1.4 Global Ursodeoxycholic Acid API Market Size by Type
- 1.4.1 Global Ursodeoxycholic Acid API Market Size Overview by Type (2021-2032)
- 1.4.2 Global Ursodeoxycholic Acid API Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Ursodeoxycholic Acid API Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Ursodeoxycholic Acid API Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Ursodeoxycholic Acid API Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Ursodeoxycholic Acid API Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Ursodeoxycholic Acid API Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Ursodeoxycholic Acid API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Ursodeoxycholic Acid API Industry Trends
- 2.2 Ursodeoxycholic Acid API Industry Drivers
- 2.3 Ursodeoxycholic Acid API Industry Opportunities and Challenges
- 2.4 Ursodeoxycholic Acid API Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Ursodeoxycholic Acid API Revenue (2021-2026)
- 3.2 Global Top Players by Ursodeoxycholic Acid API Sales (2021-2026)
- 3.3 Global Top Players by Ursodeoxycholic Acid API Price (2021-2026)
- 3.4 Global Ursodeoxycholic Acid API Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ursodeoxycholic Acid API Major Company Production Sites & Headquarters
- 3.6 Global Ursodeoxycholic Acid API Company, Product Type & Application
- 3.7 Global Ursodeoxycholic Acid API Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ursodeoxycholic Acid API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ursodeoxycholic Acid API Players Market Share by Revenue in 2025
- 3.8.3 2025 Ursodeoxycholic Acid API Tier 1, Tier 2, and Tier 3
4 Ursodeoxycholic Acid API Regional Status and Outlook
- 4.1 Global Ursodeoxycholic Acid API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Ursodeoxycholic Acid API Historic Market Size by Region
- 4.2.1 Global Ursodeoxycholic Acid API Sales in Volume by Region (2021-2026)
- 4.2.2 Global Ursodeoxycholic Acid API Sales in Value by Region (2021-2026)
- 4.2.3 Global Ursodeoxycholic Acid API Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Ursodeoxycholic Acid API Forecasted Market Size by Region
- 4.3.1 Global Ursodeoxycholic Acid API Sales in Volume by Region (2027-2032)
- 4.3.2 Global Ursodeoxycholic Acid API Sales in Value by Region (2027-2032)
- 4.3.3 Global Ursodeoxycholic Acid API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ursodeoxycholic Acid API by Application
- 5.1 Ursodeoxycholic Acid API Market by Application
- 5.1.1 Pharmacy
- 5.1.2 Health Products
- 5.2 Global Ursodeoxycholic Acid API Market Size by Application
- 5.2.1 Global Ursodeoxycholic Acid API Market Size Overview by Application (2021-2032)
- 5.2.2 Global Ursodeoxycholic Acid API Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Ursodeoxycholic Acid API Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Ursodeoxycholic Acid API Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Ursodeoxycholic Acid API Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Ursodeoxycholic Acid API Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Ursodeoxycholic Acid API Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Ursodeoxycholic Acid API Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 ICE
- 6.1.1 ICE Company Information
- 6.1.2 ICE Business Overview
- 6.1.3 ICE Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 ICE Ursodeoxycholic Acid API Product Portfolio
- 6.1.5 ICE Recent Developments
- 6.2 Grindeks
- 6.2.1 Grindeks Company Information
- 6.2.2 Grindeks Business Overview
- 6.2.3 Grindeks Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Grindeks Ursodeoxycholic Acid API Product Portfolio
- 6.2.5 Grindeks Recent Developments
- 6.3 Mitsubishi
- 6.3.1 Mitsubishi Company Information
- 6.3.2 Mitsubishi Business Overview
- 6.3.3 Mitsubishi Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mitsubishi Ursodeoxycholic Acid API Product Portfolio
- 6.3.5 Mitsubishi Recent Developments
- 6.4 Daewoong chemical
- 6.4.1 Daewoong chemical Company Information
- 6.4.2 Daewoong chemical Business Overview
- 6.4.3 Daewoong chemical Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Daewoong chemical Ursodeoxycholic Acid API Product Portfolio
- 6.4.5 Daewoong chemical Recent Developments
- 6.5 PharmaZell GmbH
- 6.5.1 PharmaZell GmbH Company Information
- 6.5.2 PharmaZell GmbH Business Overview
- 6.5.3 PharmaZell GmbH Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 PharmaZell GmbH Ursodeoxycholic Acid API Product Portfolio
- 6.5.5 PharmaZell GmbH Recent Developments
- 6.6 Dipharma Francis
- 6.6.1 Dipharma Francis Company Information
- 6.6.2 Dipharma Francis Business Overview
- 6.6.3 Dipharma Francis Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Dipharma Francis Ursodeoxycholic Acid API Product Portfolio
- 6.6.5 Dipharma Francis Recent Developments
- 6.7 Zhangshanbelling
- 6.7.1 Zhangshanbelling Company Information
- 6.7.2 Zhangshanbelling Business Overview
- 6.7.3 Zhangshanbelling Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Zhangshanbelling Ursodeoxycholic Acid API Product Portfolio
- 6.7.5 Zhangshanbelling Recent Developments
- 6.8 Erregierre
- 6.8.1 Erregierre Company Information
- 6.8.2 Erregierre Business Overview
- 6.8.3 Erregierre Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Erregierre Ursodeoxycholic Acid API Product Portfolio
- 6.8.5 Erregierre Recent Developments
- 6.9 Abil Chempharma
- 6.9.1 Abil Chempharma Company Information
- 6.9.2 Abil Chempharma Business Overview
- 6.9.3 Abil Chempharma Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Abil Chempharma Ursodeoxycholic Acid API Product Portfolio
- 6.9.5 Abil Chempharma Recent Developments
- 6.10 Biotavia Labs
- 6.10.1 Biotavia Labs Company Information
- 6.10.2 Biotavia Labs Business Overview
- 6.10.3 Biotavia Labs Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Biotavia Labs Ursodeoxycholic Acid API Product Portfolio
- 6.10.5 Biotavia Labs Recent Developments
- 6.11 Suzhou Tianlu
- 6.11.1 Suzhou Tianlu Company Information
- 6.11.2 Suzhou Tianlu Business Overview
- 6.11.3 Suzhou Tianlu Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Suzhou Tianlu Ursodeoxycholic Acid API Product Portfolio
- 6.11.5 Suzhou Tianlu Recent Developments
- 6.12 Arcelor Chemicals
- 6.12.1 Arcelor Chemicals Company Information
- 6.12.2 Arcelor Chemicals Business Overview
- 6.12.3 Arcelor Chemicals Ursodeoxycholic Acid API Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Arcelor Chemicals Ursodeoxycholic Acid API Product Portfolio
- 6.12.5 Arcelor Chemicals Recent Developments
7 North America by Country
- 7.1 North America Ursodeoxycholic Acid API Sales by Country
- 7.1.1 North America Ursodeoxycholic Acid API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Ursodeoxycholic Acid API Sales by Country (2021-2026)
- 7.1.3 North America Ursodeoxycholic Acid API Sales Forecast by Country (2027-2032)
- 7.2 North America Ursodeoxycholic Acid API Market Size by Country
- 7.2.1 North America Ursodeoxycholic Acid API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Ursodeoxycholic Acid API Market Size by Country (2021-2026)
- 7.2.3 North America Ursodeoxycholic Acid API Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Ursodeoxycholic Acid API Sales by Country
- 8.1.1 Europe Ursodeoxycholic Acid API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Ursodeoxycholic Acid API Sales by Country (2021-2026)
- 8.1.3 Europe Ursodeoxycholic Acid API Sales Forecast by Country (2027-2032)
- 8.2 Europe Ursodeoxycholic Acid API Market Size by Country
- 8.2.1 Europe Ursodeoxycholic Acid API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Ursodeoxycholic Acid API Market Size by Country (2021-2026)
- 8.2.3 Europe Ursodeoxycholic Acid API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Ursodeoxycholic Acid API Sales by Country
- 9.1.1 Asia-Pacific Ursodeoxycholic Acid API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Ursodeoxycholic Acid API Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Ursodeoxycholic Acid API Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Ursodeoxycholic Acid API Market Size by Country
- 9.2.1 Asia-Pacific Ursodeoxycholic Acid API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Ursodeoxycholic Acid API Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Ursodeoxycholic Acid API Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Ursodeoxycholic Acid API Sales by Country
- 10.1.1 South America Ursodeoxycholic Acid API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Ursodeoxycholic Acid API Sales by Country (2021-2026)
- 10.1.3 South America Ursodeoxycholic Acid API Sales Forecast by Country (2027-2032)
- 10.2 South America Ursodeoxycholic Acid API Market Size by Country
- 10.2.1 South America Ursodeoxycholic Acid API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Ursodeoxycholic Acid API Market Size by Country (2021-2026)
- 10.2.3 South America Ursodeoxycholic Acid API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Ursodeoxycholic Acid API Sales by Country
- 11.1.1 Middle East and Africa Ursodeoxycholic Acid API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Ursodeoxycholic Acid API Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Ursodeoxycholic Acid API Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Ursodeoxycholic Acid API Market Size by Country
- 11.2.1 Middle East and Africa Ursodeoxycholic Acid API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Ursodeoxycholic Acid API Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Ursodeoxycholic Acid API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Ursodeoxycholic Acid API Value Chain Analysis
- 12.1.1 Ursodeoxycholic Acid API Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Ursodeoxycholic Acid API Production Mode & Process
- 12.2 Ursodeoxycholic Acid API Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Ursodeoxycholic Acid API Distributors
- 12.2.3 Ursodeoxycholic Acid API Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst